肥胖是牙周炎的危险因素吗? 一个系统的审查和元分析
Fariba Esperouz1, Domenico Ciavarella1, Claudio Di Gioia2
1Department of Clinical and Experimental Medicine, School of Dentistry, University of Foggia, Foggia, Italy.
概括
肥胖显著增加患牙周炎的风险,牙疾病. 这一发现强调了体重管理对于保持口腔健康和预防牙周问题的重要性.
科学领域:
- 口腔健康研究研究 口腔健康研究
- 公共卫生与流行病学
- 代谢疾病研究研究
背景情况:
- 牙周炎是一种普遍存在的口腔炎症状况.
- 肥胖是一个全球性的健康问题,与各种慢性疾病有关.
研究的目的:
- 系统地审查和对肥胖作为牙周炎风险因素的证据进行元分析.
- 确定成年人肥胖 (BMI ≥30 kg/m2) 和牙周病之间的关联.
主要方法:
- 按照PRISMA指南进行系统审查和元分析.
- 在PubMed,Scopus和Web of Science数据库中进行的搜索.
- 聚合赔率比率以95%的置信区间计算.
主要成果:
- 包括19项研究,共有41,107名参与者.
- 在肥胖和牙周炎风险增加之间发现了显著的关联 (OR = 1.31,95% CI: 1.22-1.41).
- 确认肥胖是牙周病的危险因素.
结论:
- 肥胖与牙周炎的更高风险显著相关.
- 进一步的研究是有必要的,以探索临床影响.
- 体重管理可能在预防牙周病方面发挥作用.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Stress Prevention and Stress Management Techniques IV
230
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
230
Coronary Artery Disease I: Introduction
890
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890


